Publications

Documents de travail

000 - Gressier - Alpha Therapy WS Introduction

Wed Mar 13 00:00:00 GMT 2024

001 - Vorster - Clinical Applications of Targeted Alpha Therapy (TAT) - Present and Future

Wed Mar 13 00:00:00 GMT 2024

011 - Napoli - Radiopharmaceutical research and development at Bayer in Norway

Fri Mar 15 00:00:00 GMT 2024

012- Schultz - 203Pb 212Pb Image-guided alpha therapy for cancer - Progress and Metrology Challenges

Wed Mar 13 00:00:00 GMT 2024

013 - Fongenie - Targeted Alpha Therapy - Challenges & Opportunities

Wed Mar 13 00:00:00 GMT 2024

014 - Maruk - 224Ra standardization - radiopharmaceutical perspective

Wed Mar 13 00:00:00 GMT 2024

015 - Attia - Telix Introduction

Wed Mar 13 00:00:00 GMT 2024

016 - De Vries - NorthStar Ac-225 Program Overview

Wed Mar 13 00:00:00 GMT 2024

021 - Palm - Dosimetry and Patient Treatment Planning for TAT

Wed Mar 13 00:00:00 GMT 2024

031 - Stora - PRISMAP, The European Medical Radioisotope Programme - an emphasis on alpha emitters in theranostics approaches

Fri Mar 15 00:00:00 GMT 2024

032 - Balkin - U.S. Department of Energy Isotope Program Update and Perspective on Alpha-Emitters

Wed Mar 13 00:00:00 GMT 2024

041 - Kleynhans - Targeted alpha therapy - When chemistry meets physics in the pharmacy

Wed Mar 13 00:00:00 GMT 2024

042 - Delker - Measurement problems encountered in TAT clinical practice

Wed Mar 13 00:00:00 GMT 2024

043 - Sarnelli - Measurement problems encountered in TAT clinical practice - Radiation Safety

Wed Mar 13 00:00:00 GMT 2024

051 - Zimmerman - Overview - Metrology Hierarchy, the CCRI, and the Radionuclide Therapy and Quantitative Imaging Working Group

Wed Mar 13 00:00:00 GMT 2024

052 - Coulon - Equivalence and Comparisons for Nuclides of Interest to Medicine

Wed Mar 13 00:00:00 GMT 2024

101 - Bergeron - Traceability and Primary Standards for Alpha Emitters used in TAT

Wed Mar 13 00:00:00 GMT 2024

102 - Collins - BIPM_Alpha_Workshop_Feb2024

Wed Mar 13 00:00:00 GMT 2024

103 - Zimmerman & Graves - Dissemination of standards – needs from a clinical perspective; possible routes to secondary standards

Wed Mar 13 00:00:00 GMT 2024

104 - Miller - Additional aspects of dosimetry for Targeted Alpha Therapy

Wed Mar 13 00:00:00 GMT 2024

105 - Knoll - IAEA programs for medical imaging physics in the Member States

Wed Mar 13 00:00:00 GMT 2024

106 - DenisBacelar - AlphaMet – A European project on metrology for emerging target alpha therapies

Wed Mar 13 00:00:00 GMT 2024

107 - Gestin - From a European Astatine-211 Network to a World Astatine-211 Community

Wed Mar 13 00:00:00 GMT 2024

108 - de With - The SECURE project - a brief overview

Thu Mar 14 00:00:00 GMT 2024